XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Note 11 - Share-based Compensation (Tables)
9 Months Ended
Oct. 28, 2023
Notes Tables  
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]

 

Thirteen weeks ended

  

Thirty-nine weeks ended

 

 

October 28,

  

October 29,

  

October 28,

  

October 29,

 

($ in millions)

 

2023

  

2022

  

2023

  

2022

 

Options and employee stock purchase plan

 $1  $1  $3  $4 

Restricted stock units and performance stock units

  4   8   6   21 

Total share-based compensation expense

 $5  $9  $9  $25 

 

  

  

  

 

Tax benefit recognized

 $  $  $1  $2 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

 

Stock Option Plans

  

Stock Purchase Plan

 

 

October 28,

  

October 29,

  

October 28,

  

October 29,

 

 

2023

  

2022

  

2023

  

2022

 

Weighted-average risk free rate of interest

  3.3%  1.7%  3.8%  0.7%

Expected volatility

  46%  35%  40%  40%

Weighted-average expected award life (in years)

  5.1   3.8   1.0   1.0 

Dividend yield

  3.4%  2.7%  4.7%  2.3%

Weighted-average fair value

 $13.53  $10.71  $6.28  $20.51 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]

 

  

Weighted-

  

Weighted-

 

 

Number

  

Average

  

Average

 

 

of

  

Remaining

  

Exercise

 

 

Shares

  

Contractual Life

  

Price

 

 

(in thousands)

  

(in years)

  

(per share)

 

Options outstanding at the beginning of the year

  3,256  

  $47.85 

Granted

  341  

   37.72 

Exercised

  (188) 

   24.02 

Expired or cancelled

  (603) 

   47.50 

Options outstanding at October 28, 2023

  2,806   3.5  $48.28 

Options exercisable at October 28, 2023

  2,384   2.5  $50.28 

Shares available for future grant at October 28, 2023 under the 2007 Stock Incentive Plan (1)

  11,342  

  

 

Shares available for future grant at October 28, 2023 under the employment inducement award plan (2)

  409  

  

 
Schedule of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value [Table Text Block]

 

Thirteen weeks ended

  

Thirty-nine weeks ended

 

 

October 28,

  

October 29,

  

October 28,

  

October 29,

 

($ in millions)

 

2023

  

2022

  

2023

  

2022

 

Exercised

 $  $  $3  $1 
Schedule of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Intrinsic Value of Options Outstanding and Exercisable [Table Text Block]

 

October 28,

  

October 29,

 

($ in millions)

 

2023

  

2022

 

Outstanding

 $  $7 

Outstanding and exercisable

 $  $5 
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

 

Options Outstanding

  

Options Exercisable

 

 

  

Weighted-

  

  

  

 

 

  

Average

  

Weighted-

  

  

Weighted-

 

 

  

Remaining

  

Average

  

  

Average

 

Range of Exercise

 

Number

  

Contractual

  

Exercise

  

Number

  

Exercise

 

Prices

 

Outstanding

  

Life

  

Price

  

Exercisable

  

Price

 

 

(in thousands, except prices per share and contractual life)

 

$21.60 - $30.98

  703   4.3  $24.70   609  $24.01 

$36.49 - $46.64

  695   5.4   41.77   377   44.27 

$53.61 - $58.94

  412   2.7   56.61   403   56.68 

$62.02 - $72.83

  996   1.9   66.05   995   66.05 

  2,806   3.5  $48.28   2,384  $50.28 
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]

 

  

Weighted-

     
      

Average

  

Weighted-

 

 

Number

  

Remaining

  

Average

 

 

of

  

Contractual

  

Grant Date

 

 

Shares

  

Life

  

Fair Value

 

 

(in thousands)

  

(in years)

  

(per share)

 

Nonvested at beginning of year

  1,992  

  $37.58 

Granted

  1,195  

   35.84 

Vested

  (677) 

   34.01 

Performance adjustment (1)

  (757) 

    

Forfeited

  (233) 

   39.29 

Nonvested at October 28, 2023

  1,520   1.5  $38.88 

 

  

  

 

Aggregate value ($ in millions)

 $59